Mar 15, 2023 / 10:30PM GMT
Timothy T. Goodnow - Senseonics Holdings, Inc. - President, CEO & Director
Good evening to those joining us from the U.S., and good morning to those joining us from Japan. Welcome to the Eversense Investor and Analyst Day. Thank you for all your participation. My name is Tim Goodnow, and I serve as CEO for Senseonics.
As our partners Ascensia and PHC play an important role in helping us build the Eversense franchise and increase our sales, and with Eversense CGM being an important part of Ascensia and PHC's growth initiatives, Senseonics technology and development pipeline are important to PHC's plans. Therefore, we felt it would be valuable for our respective shareholders to get to hear from each of the partners in our collaboration to round out a fuller view of our aligned vision, our respective capabilities and our shared plans to grow Eversense.
In Senseonics, 2022 was a very productive year. We received both FDA approval and a CE Mark for our Eversense E3 180-day continuous glucose monitoring system. We launched the product globally with our commercial partners, Ascensia
Senseonics Holdings Inc And PHC Holdings Corp To Host Joint Eversense CGM Analyst And Investor Event (Virtual) Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers